参考文献2016.1.15.docxVIP

Wang H, Jiang W, Zhou Z, et al. Liver transplantationin mainland China: the overview of CLTR 2011 annualscientific report[J]. HepatobiliarySurgNutr, 2013, 2( 4) : 188-197.Zheng SS, Xu X, Wu J, et al. Liver transplantation for hepatocellular carcinoma: Hangzhouexperiences[J].Transplantation, 2008, 85(12):1726-1732.Fan J, Yang GS, Fu ZR, et al. Liver transplantation outcomes in 1 078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China [J]. J Cancer Res ClinOncol, 2009, 135 (10):1403-1412.Barry C, DSouza M, McCall M, et al. Micro RNA expression profiles as adjunctive data to assess the risk ofhepatocellular carcinoma recurrence after liver transplantation[J]. Am J Transplant, 2012, 12 (2):428-437.Menon KV, Hakeem AR, Heaton ND. Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma[J]. Aliment PharmacolTher, 2013, 37(4):411-419.Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699.Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellularcarcinoma: an international consensus conference report[J]. Lancet Oncol, 2012, 13(1):e11-e22.Mazzaferro V, Battiston C, Perrone S, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: aprospective study [J]. Ann Surg, 2004, 240 (5):900-909.Yao FY, Ferrell L, Bass NM, et al.Liver transplantation forhepatocellular carcinoma:comparison of the proposed UCSFcriteria with the Milan criteria and the Pittsburgh modifiedTNM criteria [J]. Liver Transpl, 2002, 8(9):765.樊嘉，周俭，徐泱，等．肝癌肝移植适应证的选择：上海复旦标准．中华医学杂志，2006, 86: 1227-1231.Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J].Lancet, 2012,379(9822):1245-255.Toso C, Merani S, Bigam D, et al. Sirolimus-basedimmunosuppression is associated with increased survival